Skip to content

Nuvalent, Inc. NUVL Other operating expenses

Other operating expenses at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-0.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$200K
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s other operating expenses?
Nuvalent, Inc. (NUVL) reported other operating expenses of $119.41M in Q1 2026.
How has Nuvalent, Inc.'s other operating expenses changed year-over-year?
Nuvalent, Inc.'s other operating expenses increased by 25.9% year-over-year, from $94.81M to $119.41M.
What is the long-term trend for Nuvalent, Inc.'s other operating expenses?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s other operating expenses has grown at a 73.4% compound annual growth rate (CAGR), from $45.82M to $414.31M.